DE69525354T2 - Eine neuartige medizinische verwendung eines 5ht 3-antagonisten - Google Patents
Eine neuartige medizinische verwendung eines 5ht 3-antagonistenInfo
- Publication number
- DE69525354T2 DE69525354T2 DE69525354T DE69525354T DE69525354T2 DE 69525354 T2 DE69525354 T2 DE 69525354T2 DE 69525354 T DE69525354 T DE 69525354T DE 69525354 T DE69525354 T DE 69525354T DE 69525354 T2 DE69525354 T2 DE 69525354T2
- Authority
- DE
- Germany
- Prior art keywords
- antagonist
- medical use
- new medical
- new
- impotence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25152194 | 1994-09-19 | ||
PCT/JP1995/001745 WO1996009069A1 (fr) | 1994-09-19 | 1995-08-31 | Nouvelle utilisation medicale d'un antagoniste de 5ht¿3? |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69525354D1 DE69525354D1 (de) | 2002-03-21 |
DE69525354T2 true DE69525354T2 (de) | 2002-08-14 |
Family
ID=17224055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69525354T Expired - Fee Related DE69525354T2 (de) | 1994-09-19 | 1995-08-31 | Eine neuartige medizinische verwendung eines 5ht 3-antagonisten |
Country Status (8)
Country | Link |
---|---|
US (1) | US5750537A (de) |
EP (1) | EP0781561B1 (de) |
JP (1) | JP3823194B2 (de) |
AT (1) | ATE212860T1 (de) |
AU (1) | AU3354895A (de) |
DE (1) | DE69525354T2 (de) |
ES (1) | ES2167457T3 (de) |
WO (1) | WO1996009069A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6399618B1 (en) | 1997-07-09 | 2002-06-04 | Cardiome Pharma Corp | Compositions and methods for modulating sexual activity |
US6037360A (en) * | 1997-10-28 | 2000-03-14 | Vivus, Incorporated | Administration of 5-HT3 receptor antagonists to treat premature ejaculation |
US6228864B1 (en) | 1997-10-28 | 2001-05-08 | Vivus, Inc. | Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation |
KR100631299B1 (ko) * | 1998-04-01 | 2006-10-09 | 카디오메 파마 코포레이션 | 아미노사이클로헥실 에테르 화합물 및 이를 포함하는 약제학적 조성물 |
US6974838B2 (en) | 1998-08-24 | 2005-12-13 | Sepracor Inc. | Methods of treating or preventing pain using sibutramine metabolites |
US6339106B1 (en) | 1999-08-11 | 2002-01-15 | Sepracor, Inc. | Methods and compositions for the treatment and prevention of sexual dysfunction |
AU2007200334B8 (en) * | 1998-08-24 | 2010-10-21 | Sepracor, Inc. | Methods of using and compositions comprising dopamine reuptake inhibitors |
US6476078B2 (en) | 1999-08-11 | 2002-11-05 | Sepracor, Inc. | Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction |
US6331571B1 (en) | 1998-08-24 | 2001-12-18 | Sepracor, Inc. | Methods of treating and preventing attention deficit disorders |
US7507545B2 (en) | 1999-03-31 | 2009-03-24 | Cardiome Pharma Corp. | Ion channel modulating activity method |
US6399826B1 (en) | 1999-08-11 | 2002-06-04 | Sepracor Inc. | Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain |
US7524879B2 (en) * | 2000-10-06 | 2009-04-28 | Cardiome Pharma Corp. | Ion channel modulating compounds and uses thereof |
US7057053B2 (en) * | 2000-10-06 | 2006-06-06 | Cardiome Pharma Corp. | Ion channel modulating compounds and uses thereof |
WO2002083631A1 (en) | 2001-04-13 | 2002-10-24 | Sepracor Inc. | Methods of preparing didesmethylsibutramine and other sibutramine derivatives |
US7345086B2 (en) * | 2003-05-02 | 2008-03-18 | Cardiome Pharma Corp. | Uses of ion channel modulating compounds |
US20090041841A1 (en) * | 2003-05-02 | 2009-02-12 | Cardiome Pharma Corp. | Controlled release tablet formulations for the prevention of arrhythmias |
CA2524323C (en) * | 2003-05-02 | 2012-05-15 | Cardiome Pharma Corp. | Aminocyclohexyl ether compounds and uses thereof |
WO2005018635A2 (en) * | 2003-08-07 | 2005-03-03 | Cardiome Pharma Corp. | Ion channel modulating activity i |
US7345087B2 (en) * | 2003-10-31 | 2008-03-18 | Cardiome Pharma Corp. | Aminocyclohexyl ether compounds and uses thereof |
US7977373B2 (en) | 2004-04-01 | 2011-07-12 | Cardiome Pharma Corp. | Prodrugs of ion channel modulating compounds and uses thereof |
WO2005097087A2 (en) * | 2004-04-01 | 2005-10-20 | Cardiome Pharma Corp. | Merged ion channel modulating compounds and uses thereof |
JP5583325B2 (ja) * | 2004-11-08 | 2014-09-03 | カーディオム ファーマ コーポレイション | イオンチャネル調節化合物の投与レジメ |
US20110288115A1 (en) * | 2010-05-24 | 2011-11-24 | Avmedis Llc | Treatment of vagally-mediated spectrum disorders |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
AU627221B2 (en) * | 1988-09-27 | 1992-08-20 | Fujisawa Pharmaceutical Co., Ltd. | Pyridoindole derivatives and processes for preparation thereof |
US5173493A (en) * | 1988-09-27 | 1992-12-22 | Fujisawa Pharmaceutical Company, Ltd. | Pyridoindole derivatives and processes for preparation thereof |
US5290785A (en) * | 1988-09-27 | 1994-03-01 | Fujisawa Pharmaceutical Co., Ltd. | Therapeutic agent for ischemic diseases |
US4914107A (en) * | 1989-01-17 | 1990-04-03 | Eli Lilly And Company | Method for selectively blocking 5-HT2 receptors |
CN1118990A (zh) * | 1993-03-08 | 1996-03-20 | 藤泽药品工业株式会社 | 治疗或预防脑血管疾病药物 |
US5300645A (en) * | 1993-04-14 | 1994-04-05 | Eli Lilly And Company | Tetrahydro-pyrido-indole |
-
1995
- 1995-08-31 JP JP52557695A patent/JP3823194B2/ja not_active Expired - Fee Related
- 1995-08-31 DE DE69525354T patent/DE69525354T2/de not_active Expired - Fee Related
- 1995-08-31 AT AT95930029T patent/ATE212860T1/de not_active IP Right Cessation
- 1995-08-31 WO PCT/JP1995/001745 patent/WO1996009069A1/ja active IP Right Grant
- 1995-08-31 AU AU33548/95A patent/AU3354895A/en not_active Abandoned
- 1995-08-31 US US08/793,798 patent/US5750537A/en not_active Expired - Fee Related
- 1995-08-31 ES ES95930029T patent/ES2167457T3/es not_active Expired - Lifetime
- 1995-08-31 EP EP95930029A patent/EP0781561B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69525354D1 (de) | 2002-03-21 |
AU3354895A (en) | 1996-04-09 |
EP0781561B1 (de) | 2002-02-06 |
ATE212860T1 (de) | 2002-02-15 |
US5750537A (en) | 1998-05-12 |
WO1996009069A1 (fr) | 1996-03-28 |
EP0781561A4 (de) | 1997-08-20 |
ES2167457T3 (es) | 2002-05-16 |
EP0781561A1 (de) | 1997-07-02 |
JP3823194B2 (ja) | 2006-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69525354T2 (de) | Eine neuartige medizinische verwendung eines 5ht 3-antagonisten | |
NO870241L (no) | Hypoglykemiske tiazolidindioner. | |
ES2190469T3 (es) | Derivados de isocumarina y su uso en farmacos. | |
DE69332800T2 (de) | Rohrförmige, medizinische prothese | |
SE9604786D0 (sv) | New compounds | |
MX9102407A (es) | 4 arilpiperazinas y 4-arilpiperidinas novedosas. | |
ES2176204T3 (es) | Antidepresivos que contienen un derivado de xantina. | |
DK0409435T3 (da) | Heteroarylpiperaziner som antipsykotiske midler | |
FI921345A0 (fi) | Piperidinderivat. | |
IT1228288B (it) | Composti ad attivita' antiserotoninica | |
ES2127181T3 (es) | 11-beta-aril-gona-4,9-dien-3-onas. | |
ES2160649T3 (es) | Nuevos compuestos lactamicos y procedimientos para su preparacion. | |
ES2182454T3 (es) | Derivados de amida y su uso terapeutico. | |
ITMI921569A1 (it) | N(eter0)-aril-n(etero)-tetralinalchil piperazine aventi attivita' serotoninergica, dopaminergica e adrenergica | |
ATE110365T1 (de) | 2-alkyl-4-arylmethylaminochinoline, ihre verwendung und daraus hergestellte arzneimittel. | |
DE50101861D1 (de) | Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung | |
ATE74605T1 (de) | Tetracyclische chinazolinderivate, herstellung und verwendung. | |
ATE92469T1 (de) | Neue alpha-aminocarbonsaeure-derivate, ihre herstellung und verwendung. | |
ATE176233T1 (de) | Imidazo(1,2-c)chinazolinderivate als antihypertensive und antidysurie | |
EP0535250A4 (en) | Novel compounds and use thereof as medicine | |
DE69231883D1 (de) | 4-(1,1-Dialkoxycarbonyl-Alkyl)Azetidin-2-on-Derivate zur Herstellung von 4-(1-Carboxy-Alkyl)Azetidin-2-on-Derivaten | |
IT8922246A0 (it) | Procedimento di preparazione di 3-ciano-3,5,5'-trimetil-1-cicloesanone | |
ITRM910146U1 (it) | Strumento chirurgico per l'introduzione di protesi peniene. | |
ES2091570T3 (es) | Nuevos derivados peptidicos antagonistas de la bradiquidina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
ES2061550T3 (es) | Vinilcefalosporinas substituidas, procedimiento para su preparacion y su uso como medicamento. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: ASTELLAS PHARMA INC., TOKIO/TOKYO, JP |
|
8339 | Ceased/non-payment of the annual fee |